Health Canada’s regulatory response to COVID-19: Access to health products
Description
Health Canada introduced innovative and agile regulatory measures. These measures expedite the regulatory review of COVID-19 health products without compromising safety, efficacy and quality standards.
Resources
| Name |
Format |
Description |
Link |
| Health Canada’s regulatory response to COVID-19: Access to health products |
HTML |
|
https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/regulatory-response-health-product-access.html |
| Health Canada’s regulatory response to COVID-19: Access to health products |
HTML |
|
https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/covid19-industrie/reponse-reglementation-acces-produits-sante.html |